GLOBAL HIV VACCINE ENTERPRISE
$1,270,842N01FY2012AINIH
Global Hiv Vaccine Enterprise, New York NY
Investigators
Abstract
This contract provides funds for the Global HIV Vaccine Enterprise to develop a scientific strategic plan for HIV/AIDS research.
View original record on NIH RePORTER →